The EC has approved Daiichi Sankyo and AstraZeneca’s Enhertu for use as a single agent to treat adults with certain breast ...

Streeting said his June 10-year plan will address drug sale clawbacks, NICE regulation, and the abolition of NHS England.

This week, the Trump administration followed through on its planned mass layoffs at agencies under the US Department of ...

Sanofi's reversible BTK inhibitor rilzabrutinib has gained the US Food and Drug Administration’s (FDA) orphan drug ...

If preclinical findings were translated into the clinic, they could shorten the CAR-T generation lead time from two weeks to ...

Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early ...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Boehringer Ingelheim subsidiary NBE Therapeutics has opened its new antibody-drug conjugates (ADC) R&D facility in Basel, Switzerland.

UK Government drug sale clawbacks must be eased for pharma innovation to meet its ten-year plan, say industry representatives ...

Atsena Therapeutics has completed an oversubscribed Series C financing round, raising $150m to support the advancement of ...

Reduced frequency is very encouraging for patient compliance and could help those who dislike weekly injections and ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.